重度哮喘在组织炎症受抑情况下仍存在:U-BIOPRED研究
U-BIOPRED是一项欧洲多中心研究,纳入接受激素治疗的成人哮喘患者(重度非吸烟者、重度现吸烟/既往吸烟者、轻中度患者)及健康对照,通过支气管镜亚组研究比较支气管免疫病理。158名参与者的支气管活检和支气管上皮刷检显示,健康对照组黏膜下肥大细胞数高于两个重度哮喘组和轻中度组,重度现吸烟/既往吸烟组CD4+淋巴细胞数低于其他三组,未见其他差异。结论认为,在目前推荐治疗下,非吸烟和吸烟重度哮喘患者近端气道壁组织炎症受抑,但重度哮喘仍然存在。
要点
- 健康对照黏膜下肥大细胞数高于重度哮喘与轻中度哮喘组
- 重度现吸烟/既往吸烟哮喘组CD4+淋巴细胞数低于其他三组
- 接受推荐治疗的重度哮喘患者近端气道壁组织炎症受抑但疾病仍存在
核心结论
- 在非吸烟和吸烟重度哮喘患者中,尽管近端气道壁组织炎症受抑,重度哮喘仍然存在。
研究设计与样本
- U-BIOPRED为欧洲多中心横断面支气管镜亚组研究,纳入158名参与者,收集支气管活检与支气管上皮刷检进行免疫病理和转录组分析。
- 分组包括接受激素治疗的成人重度非吸烟哮喘组、重度现吸烟/既往吸烟哮喘组、轻中度哮喘组及健康对照组。
主要发现
- 健康对照黏膜下肥大细胞数为33.6 mm-2,高于重度非吸烟组17.4 mm-2(p<0.001)、重度现吸烟/既往吸烟组22.2 mm-2(p=0.01)和轻中度组21.2 mm-2(p=0.01)。
- 重度现吸烟/既往吸烟组CD4+淋巴细胞数为4.7 mm-2,低于重度非吸烟组11.6 mm-2(p=0.002)、轻中度组10.1 mm-2(p=0.008)和健康对照10.6 mm-2(p<0.001)。
- 未观察到其他差异。
关键数值与推荐
- Affymetrix芯片分析在支气管刷检样本中识别出7个与黏膜下嗜酸性粒细胞呈正相关的探针对应COX-2、ADAM-7、SLCO1A2、TMEFF2和TRPM-1,其余两个未命名。
临床怎么用
- 提示评估重度哮喘时不应仅依据近端气道组织炎症水平判断疾病活动度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The U-BIOPRED study is a multicentre European study aimed at a better understanding of severe asthma. It included three steroid-treated adult asthma groups (severe nonsmokers (SAn group), severe current/ex-smokers (SAs/ex group) and those with mild-moderate disease (MMA group)) and healthy controls (HC group). The aim of this cross-sectional, bronchoscopy substudy was to compare bronchial immunopathology between these groups.In 158 participants, bronchial biopsies and bronchial epithelial brushings were collected for immunopathologic and transcriptomic analysis. Immunohistochemical analysis of glycol methacrylate resin-embedded biopsies showed there were more mast cells in submucosa of the HC group (33.6 mm-2) compared with both severe asthma groups (SAn: 17.4 mm-2, p<0.001; SAs/ex: 22.2 mm-2, p=0.01) and with the MMA group (21.2 mm-2, p=0.01). The number of CD4+ lymphocytes was decreased in the SAs/ex group (4.7 mm-2) compared with the SAn (11.6 mm-2, p=0.002), MMA (10.1 mm-2, p=0.008) and HC (10.6 mm-2, p<0.001) groups. No other differences were observed.Affymetrix microarray analysis identified seven probe sets in the bronchial brushing samples that had a positive relationship with submucosal eosinophils. These mapped to COX-2 (cyclo-oxygenase-2), ADAM-7 (disintegrin and metalloproteinase domain-containing protein 7), SLCO1A2 (solute carrier organic anion transporter family member 1A2), TMEFF2 (transmembrane protein with epidermal growth factor like and two follistatin like domains 2) and TRPM-1 (transient receptor potential cation channel subfamily M member 1); the remaining two are unnamed.We conclude that in nonsmoking and smoking patients on currently recommended therapy, severe asthma exists despite suppressed tissue inflammation within the proximal airway wall.
引用
- Wilson SJ, Ward JA, Sousa AR, et al. Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study. Eur Respir J. 2016. PMID: 27799384. doi:10.1183/13993003.01129-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。